1958 related items for PubMed ID: 18405787
1. The effects of amlodipine and enalapril on renal function in adults with hypertension and nondiabetic nephropathies: a 3-year, randomized, multicenter, double-blind, placebo-controlled study.
Esnault VL, Brown EA, Apetrei E, Bagon J, Calvo C, DeChatel R, Holdaas H, Krcmery S, Kobalava Z, Amlodipine Versus Enalapril in Renal failure (AVER) Study Group.
Clin Ther; 2008 Mar; 30(3):482-98. PubMed ID: 18405787
[Abstract] [Full Text] [Related]
2. Renal outcomes in high-risk hypertensive patients treated with an angiotensin-converting enzyme inhibitor or a calcium channel blocker vs a diuretic: a report from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).
Rahman M, Pressel S, Davis BR, Nwachuku C, Wright JT, Whelton PK, Barzilay J, Batuman V, Eckfeldt JH, Farber M, Henriquez M, Kopyt N, Louis GT, Saklayen M, Stanford C, Walworth C, Ward H, Wiegmann T.
Arch Intern Med; 2005 Apr 25; 165(8):936-46. PubMed ID: 15851647
[Abstract] [Full Text] [Related]
3. Results of a phase III, 8-week, multicenter, prospective, randomized, double-blind, parallel-group clinical trial to assess the effects of amlodipine camsylate versus amlodipine besylate in Korean adults with mild to moderate hypertension.
Kim SH, Kim YD, Lim DS, Yoon MH, Ahn YK, On YK, Lee JW, Kim IJ, Park JB, Kim JJ, Chung WS, Yang JY, Seo HS, Shin EK, Kim HS, Korean Multicenter Amlodipine Study Investigators.
Clin Ther; 2007 Sep 25; 29(9):1924-36. PubMed ID: 18035192
[Abstract] [Full Text] [Related]
4. Tolerability and blood pressure-lowering efficacy of the combination of amlodipine plus valsartan compared with lisinopril plus hydrochlorothiazide in adult patients with stage 2 hypertension.
Poldermans D, Glazes R, Kargiannis S, Wernsing M, Kaczor J, Chiang YT, Yen J, Gamboa R, Fomina I.
Clin Ther; 2007 Feb 25; 29(2):279-89. PubMed ID: 17472820
[Abstract] [Full Text] [Related]
5. An 18-week, prospective, randomized, double-blind, multicenter study of amlodipine/ramipril combination versus amlodipine monotherapy in the treatment of hypertension: the assessment of combination therapy of amlodipine/ramipril (ATAR) study.
Miranda RD, Mion D, Rocha JC, Kohlmann O, Gomes MA, Saraiva JF, Amodeo C, Filho BL.
Clin Ther; 2008 Sep 25; 30(9):1618-28. PubMed ID: 18840367
[Abstract] [Full Text] [Related]
6. Two multicenter, 8-week, randomized, double-blind, placebo-controlled, parallel-group studies evaluating the efficacy and tolerability of amlodipine and valsartan in combination and as monotherapy in adult patients with mild to moderate essential hypertension.
Philipp T, Smith TR, Glazer R, Wernsing M, Yen J, Jin J, Schneider H, Pospiech R.
Clin Ther; 2007 Apr 25; 29(4):563-80. PubMed ID: 17617280
[Abstract] [Full Text] [Related]
7. Effect of pentoxifylline on GFR decline in CKD: a pilot, double-blind, randomized, placebo-controlled trial.
Perkins RM, Aboudara MC, Uy AL, Olson SW, Cushner HM, Yuan CM.
Am J Kidney Dis; 2009 Apr 25; 53(4):606-16. PubMed ID: 19216016
[Abstract] [Full Text] [Related]
8. Hong Kong study using valsartan in IgA nephropathy (HKVIN): a double-blind, randomized, placebo-controlled study.
Li PK, Leung CB, Chow KM, Cheng YL, Fung SK, Mak SK, Tang AW, Wong TY, Yung CY, Yung JC, Yu AW, Szeto CC, HKVIN Study Group.
Am J Kidney Dis; 2006 May 25; 47(5):751-60. PubMed ID: 16632013
[Abstract] [Full Text] [Related]
9. A randomized and double-blind comparison of isradipine and spirapril as monotherapy and in combination on the decline in renal function in patients with chronic renal failure and hypertension.
Petersen LJ, Petersen JR, Talleruphuus U, Møller ML, Ladefoged SD, Mehlsen J, Jensen HA.
Clin Nephrol; 2001 May 25; 55(5):375-83. PubMed ID: 11393383
[Abstract] [Full Text] [Related]
10. Are angiotensin converting enzyme inhibitors superior to beta blockers in retarding progressive renal function decline?
van Essen GG, Apperloo AJ, Rensma PL, Stegeman CA, Sluiter WJ, de Zeeuw D, de Jong PE.
Kidney Int Suppl; 1997 Dec 25; 63():S58-62. PubMed ID: 9407423
[Abstract] [Full Text] [Related]
11. Efficacy and tolerability of manidipine in the treatment of hypertension in patients with non-diabetic chronic kidney disease without glomerular disease. Prospective, randomized, double-blind study of parallel groups in comparison with enalapril.
Del Vecchio L, Pozzi M, Salvetti A, Maschio G, Fusaroli M, Rovati C, Antonucci F, Cascone C, Scanferla F, Panichi V, Sturani A, Locatelli F, Manidipine Study Group.
J Nephrol; 2004 Dec 25; 17(2):261-9. PubMed ID: 15293527
[Abstract] [Full Text] [Related]
12. [Renal hemodynamics and proteinuria in chronic glomerulonephritis treated with beta-receptor blockers or ace inhibitors].
Erley CM, Berger ED, Heyne N, Klass M, Krämer D, Braun N, Wolf S, Risler T.
Dtsch Med Wochenschr; 1997 Aug 01; 122(31-32):953-8. PubMed ID: 9280714
[Abstract] [Full Text] [Related]
13. Results of a multicenter, 8-week, parallel-group, randomized,double-blind, double-dummy, Phase III clinical trial to evaluate the efficacy and tolerability of amlodipine maleate versus amlodipine besylate in Korean patients with mild to moderate hypertension.
Park S, Chung N, Kwon J, Yoon JH, Kim YJ, Han DS, Kim HS.
Clin Ther; 2005 Apr 01; 27(4):441-50. PubMed ID: 15922817
[Abstract] [Full Text] [Related]
14. A randomized, controlled, multicenter study to compare prazosin GITS with enalapril in hypertensive patients with diabetes mellitus. Bombay Hypertension Study Group.
Joglekar SJ, Nanivadekar AS.
J Assoc Physicians India; 1998 Apr 01; Suppl 1():52-62. PubMed ID: 11233387
[Abstract] [Full Text] [Related]
15. Efficacy and safety of delapril plus manidipine compared with enalapril plus hydrochlorothiazide in mild to moderate essential hypertension: results of a randomized trial.
Mugellini A, Dobovisek J, Planinc D, Cremonesi G, Fogari R.
Clin Ther; 2004 Sep 01; 26(9):1419-26. PubMed ID: 15531004
[Abstract] [Full Text] [Related]
16. Clinic blood pressure responses to two amlodipine salt formulations, adipate and besylate, in adult Korean patients with mild to moderate hypertension: a multicenter, randomized, double-blind, parallel-group, 8-week comparison.
Lee HY, Kang HJ, Koo BK, Oh BH, Heung-Sun K, Kim KS, Seo HS, Ro YM, Kang JH, Woong CJ, Joo SJ, Kim MH, Joon-Han S, Yoon J, Park SH, Jin-Ok J, Ju AK, Chong-Yun R, Yeon KJ, Park KM, Lim DK, Park SY, Amostar Study Investigators.
Clin Ther; 2005 Jun 01; 27(6):728-39. PubMed ID: 16117979
[Abstract] [Full Text] [Related]
17. Renal and cardiac effects of antihypertensive treatment with ramipril vs metoprolol in autosomal dominant polycystic kidney disease.
Zeltner R, Poliak R, Stiasny B, Schmieder RE, Schulze BD.
Nephrol Dial Transplant; 2008 Feb 01; 23(2):573-9. PubMed ID: 17984104
[Abstract] [Full Text] [Related]
18. Verapamil versus amlodipine in proteinuric non-diabetic nephropathies treated with trandolapril (VVANNTT study): design of a prospective randomized multicenter trial.
Boero R, Rollino C, Massara C, Vagelli G, Gonella M, Berto IM, Bajardi P, Perosa P, Malcangi U, Giorgi MP, Ghezzi PM, Borzumati M, Baroni AM, Cogno C, Triolo G, Angelini D, Antonelli A, Quarello F.
J Nephrol; 2001 Feb 01; 14(1):15-8. PubMed ID: 11281338
[Abstract] [Full Text] [Related]
19. Effect of lacidipine, a dihydropyridine calcium antagonist on renal function of hypertensive patients with renal insufficiency.
Bailey RR, Shand BI, Smith AH, Robson RA, Lynn KL.
Clin Nephrol; 1997 Oct 01; 48(4):224-9. PubMed ID: 9352156
[Abstract] [Full Text] [Related]
20. Shifting trends in the pharmacologic treatment of hypertension in a Nigerian tertiary hospital: a real-world evaluation of the efficacy, safety, rationality and pharmaco-economics of old and newer antihypertensive drugs.
Adigun AQ, Ishola DA, Akintomide AO, Ajayi AA.
J Hum Hypertens; 2003 Apr 01; 17(4):277-85. PubMed ID: 12714973
[Abstract] [Full Text] [Related]
Page: [Next] [New Search]
